A New Lead Identification Strategy: Screening an sp3 -rich and Lead-like Compound Library Composed of 7-Azanorbornane Derivatives

ChemMedChem. 2019 Nov 6;14(21):1840-1848. doi: 10.1002/cmdc.201900398. Epub 2019 Sep 20.

Abstract

Although the advantages of sp3 -rich, sterically complicated molecules in drug development have been pointed out, modern screening libraries are filled with planar, sp2 -rich components. Compounds that are sp3 -rich are difficult to synthesize, and thus we aimed to invent an efficient method to construct sp3 -rich libraries. By modifying sp3 -rich 7-azanorbornane scaffolds through click chemistry, we efficiently prepared a small set of compounds. These compounds were not only sp3 -rich, but also had sufficient "lead-like" properties in view of molecular weights and hydrophobicity. Screening assays of this library provided weak κ opioid receptor agonists and growth hormone secretagogue receptor agonists with high hit rates. These results indicate that the 7-azanorbornane scaffold may be a "privileged structure" for lead identification in drug discovery.

Keywords: 7-azanorbornane; drug design; lead identification; medicinal chemistry; sp3 carbon atoms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aza Compounds / chemistry*
  • Aza Compounds / pharmacology
  • Cells, Cultured
  • HEK293 Cells
  • Humans
  • Molecular Structure
  • Norbornanes / chemistry*
  • Norbornanes / pharmacology
  • Receptors, Ghrelin / agonists
  • Small Molecule Libraries / chemistry*
  • Small Molecule Libraries / pharmacology
  • Solubility
  • Thermodynamics
  • Water / chemistry

Substances

  • Aza Compounds
  • Norbornanes
  • Receptors, Ghrelin
  • Small Molecule Libraries
  • Water